David R Karp Selected Research

David R Karp Research Topics

Disease

12	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 09/2005
5	Autoimmune Diseases (Autoimmune Disease) 03/2022 - 02/2010
4	Communicable Diseases (Infectious Diseases) 01/2022 - 10/2013
3	Venous Thrombosis (Deep-Vein Thrombosis) 03/2022 - 09/2018
3	Rheumatoid Arthritis 11/2020 - 03/2011
2	Thrombosis (Thrombus) 03/2022 - 09/2018
2	Lupus Nephritis 01/2021 - 09/2005
2	Infections 01/2021 - 02/2010
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 12/2020 - 09/2018
1	Asthma (Bronchial Asthma) 01/2021
1	Tuberculosis (Tuberculoses) 01/2021
1	Eczema 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Muscular Diseases (Myopathy) 01/2020
1	Myocarditis (Carditis) 01/2020
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2020
1	Rheumatic Diseases (Rheumatism) 01/2020
1	Hypertension (High Blood Pressure) 09/2018
1	Chronic Kidney Failure (Chronic Renal Failure) 12/2017
1	Vitamin D Deficiency 01/2017
1	Fatigue 08/2015
1	Virus Diseases (Viral Diseases) 10/2013
1	Neoplasms (Cancer) 10/2013
1	Dyslipidemias (Dyslipidemia) 10/2013
1	Diabetes Mellitus 10/2013
1	Chronic Disease (Chronic Diseases) 10/2013
1	Inflammation (Inflammations) 01/2013
1	Celiac Disease (Celiac Sprue) 03/2011
1	Systemic Scleroderma (Systemic Sclerosis) 02/2010
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2005
1	Hypersensitivity (Allergy) 05/2003
1	Pneumococcal Infections 12/2002

Drug/Important Bio-Agent (IBA)

7	AutoantibodiesIBA 01/2022 - 09/2005
5	AntibodiesIBA 12/2020 - 01/2014
3	Antiphospholipid AntibodiesIBA 03/2022 - 09/2018
3	Immunoglobulin G (IgG)IBA 01/2021 - 12/2002
3	Proteins (Proteins, Gene)FDA Link 11/2020 - 02/2010
2	Complement System Proteins (Complement)IBA 01/2020 - 09/2005
2	AutoantigensIBA 01/2014 - 03/2011
2	Nucleic AcidsIBA 01/2014 - 01/2013
1	Cell-Free Nucleic AcidsIBA 03/2022
1	Histones (Histone)IBA 03/2022
1	serum P-component (CIt)IBA 03/2022
1	CytokinesIBA 01/2021
1	Rituximab (Mabthera)FDA Link 01/2021
1	belimumabIBA 01/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021
1	Immunoglobulin M (IgM)IBA 12/2020
1	durvalumabIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020
1	B7-H1 AntigenIBA 01/2020
1	CTLA-4 AntigenIBA 01/2020
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 09/2018
1	Vitamin D3 24-HydroxylaseIBA 01/2017
1	hydroxide ionIBA 01/2017
1	Vitamin D FDA LinkGeneric 01/2017
1	Prostaglandins AIBA 08/2015
1	AntioxidantsIBA 08/2015
1	Fish OilsIBA 08/2015
1	NADPH Oxidases (NAD(P)H oxidase)IBA 03/2014
1	Carrier Proteins (Binding Protein)IBA 01/2014
1	Biomarkers (Surrogate Marker)IBA 01/2014
1	Therapeutic UsesIBA 10/2013
1	Pharmaceutical PreparationsIBA 10/2013
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 10/2013
1	Biological ProductsIBA 03/2011
1	cyclic citrullinated peptideIBA 03/2011
1	Interferon Type IIBA 03/2011
1	HLA-DRB1 Chains (HLA DRB1)IBA 02/2010
1	HLA Antigens (Human Leukocyte Antigens)IBA 02/2010
1	Peptides (Polypeptides)IBA 02/2010
1	Amino Acids FDA Link 02/2010
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 11/2005
1	C-Reactive ProteinIBA 11/2005
1	MetalsIBA 05/2003
1	Complement Receptors (Complement Receptor)IBA 12/2002

Therapy/Procedure

4	Therapeutics 01/2020 - 10/2013
3	Critical Care (Surgical Intensive Care) 01/2022 - 11/2020